Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway-Reference-Cited by-同舟云学术

Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway

Published:2022-11-25 Issue: Volume: Page:
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Liu Ying,Yang Changmou,Chen Shisheng,Liu Weihao,Liang Jingyi,He Shuhua,Hui Jialiang^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

https://www.nature.com/articles/s41417-022-00563-1.pdf

Reference44 articles.

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30.

3. Beltran H, Beer TM, Carducci MA, de Bono J, Gleave M, Hussain M, et al. New therapies for castration-resistant prostate cancer: efficacy and safety. Eur Urol. 2011;60:279–90.

4. Suzman DL, Boikos SA, Carducci MA. Bone-targeting agents in prostate cancer. Cancer Metastasis Rev. 2014;33:619–28.

5. Hashimoto K, Ochi H, Sunamura S, Kosaka N, Mabuchi Y, Fukuda T, et al. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A. Proc Natl Acad Sci USA. 2018;115:2204–9.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal miRNAs: the tumor's trojan horse in selective metastasis;Molecular Cancer;2024-08-20

2. Novel liquid biopsy CNV biomarkers in malignant melanoma;Scientific Reports;2024-07-09

3. Interplay between Wnt signaling molecules and exosomal miRNAs in breast cancer (Review);Oncology Reports;2024-06-28

4. The regulatory process and practical significance of non-coding RNA in the dissemination of prostate cancer to the skeletal system;Frontiers in Oncology;2024-03-21

5. Hyperglycemia and microRNAs in prostate cancer;Prostate Cancer and Prostatic Diseases;2024-02-24